Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

7 clinical studies listed.

Filters:

Stem Cell

Tundra lists 7 Stem Cell clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06004063

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-18

1 state

Stem Cell
RECRUITING

NCT07797673

Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia

Biliary atresia is a progressive liver disease in infants where liver transplantation is often the only long-term option once cirrhosis develops. However, organ shortages, high costs, risks of graft rejection, and the need for lifelong immunosuppression make transplantation difficult for many families. This double-blind randomized clinical trial evaluates whether injecting umbilical cord-mesenchymal stem cells directly into the liver during Kasai portoenterostomy is safe and effective as an additional treatment. Umbilical cord stem cells have strong anti-inflammatory and anti-fibrotic properties, and they carry a low risk of immune rejection. Patients undergoing the Kasai procedure are randomly assigned to receive either direct intrahepatic stem cell injections or a placebo. Participants are followed for 180 days post-surgery to monitor safety, liver function, and changes in liver stiffness.

Gender: All

Ages: 30 Days - 90 Days

Updated: 2026-09-09

1 state

Biliary Atresia
Kasai Operation
Liver Fibrosis
+2
RECRUITING

NCT07227883

Secretome Treatment for Facial Rejuvenation

Secretome treatment for facial rejuvenation

Gender: All

Ages: 30 Years - 75 Years

Updated: 2026-07-06

1 state

Facial Aging
Rejuvenation
Stem Cell
+1
RECRUITING

NCT03947450

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

This study is a clinical trial testing the safety and efficacy of volar fibroblast (skin cells from the palm or sole) injections for thickening the epidermal (skin) layer at the stump site in people with below the knee amputations. The study will enroll adults seen at Johns Hopkins.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-06-09

1 state

Amputation
Skin Wound
Stem Cell
NOT YET RECRUITING

NCT07589478

Augmentation of Arthroscopic Rotator Cuff Repair With Reimplantation of Subacromial Bursa Tissue and Platelet-Rich Plasma

The goal of this observational study is to evaluate the clinical and radiographic outcomes of the biological enhancement of the arthroscopic rotator cuff repair with stem cells from the acromial bursa and PRP in individuals who undergo arthroscopic cuff repair The main question it aims to answer is: Do the stems cells from the acromial bursa and PRP promote healing and produce better results in arthroscopic cuff repair? Researchers will compare this population to three others the first do bnot receive any biological enchancement, the second receive only stem cells and the third receive only PRP to see if there are any differences.

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-19

Cuff Injury, Rotator
Arthroscopic Surgical Procedures
Stem Cell
+1
RECRUITING

NCT06564740

Stem Cell Applications in Biliary Atresia Patients

Recently, mesenchymal stem cell (MSC) transplantation has emerged as a promising treatment for liver cirrhosis in adults. Additionally, bone marrow-derived stem cell transplantation has shown success in treating children with biliary atresia (BA). This study aims to evaluate the efficacy of Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSC) therapy in BA through a multicentric randomized controlled trial.

Gender: All

Ages: 2 Months - 18 Years

Updated: 2024-09-19

1 state

Biliary Atresia
Fibrosis, Liver
Stem Cell
NOT YET RECRUITING

NCT06480123

Stem Cell Derived Exome for Treatment of Diabetic Foot

This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.

Gender: All

Ages: 18 Years - 90 Years

Updated: 2024-06-28

1 state

Diabetic Foot
Stem Cell